The abstract is read at the publisher; the summary is JClub's.
In adults with ischemic or nonischemic cardiomyopathy, LVEF 36% to 50%, and CMR-defined myocardial scar, ICD implantation did not reduce SCD or HSVA (7.8% vs 9.2%).
- Why it matters: Guidelines restrict primary-prevention ICDs to LVEF 35% or less, yet many sudden cardiac deaths occur in the 36% to 50% range; evidence for scar-guided ICD insertion is limited.
- What they did: In an open-label randomized trial across 18 sites in Australia, Germany, and the UK, 180 patients received a primary-prevention ICD and 173 received an implantable loop recorder, with a median 6.3-year follow-up.
- The result: SCD was lower with ICD (1.7% vs 5.8%, HR 0.26), but HSVA was not (6.7% vs 3.5%, HR 1.77); overall mortality and heart-failure hospitalization were similar.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.